ArticleThe Biochemical journal2020

Use of the Polo-like kinase 4 (PLK4) inhibitor centrinone to investigate intracellular signalling networks using SILAC-based phosphoproteomics.

Dominic P Byrne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.